netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Recent Updates - Updated items

All Formulary Amendments

  Records 1 to 12 of 12


Details
LDL Link Added : NICE TA645: Avelumab with axitinib for untreated advanced renal cell carcinoma : https://www.nice.org.uk/guidance/ta645
11/07/2023 17:26:24
(dmcdermott )
UPD sitematrix Changed from 0 to
11/07/2023 17:25:11
(dmcdermott )
UPD FurtherInformation Changed from

  • Approved as treatment for adults with advanced renal cell carcinoma when tyrosine kinase inhibitors or cytokines have not worked in line with NICE.

to
11/07/2023 17:25:11
(dmcdermott )
UPD Axitinib (Inlyta®) =
11/07/2023 17:25:10
(dmcdermott )
LDL Link Added : MHRA Drug Safety Update (July 2020): Systemically administered VEGF pathway inhibitors: risk of aneurysm and artery dissection : https://www.gov.uk/drug-safety-update/systemically-administered-vegf-pathway-inhibitors-risk-of-aneurysm-and-arte
30/06/2023 15:40:26
(rpaylor )
UPD Axitinib changed to protein kinase inhibitor
09/05/2018 11:15:39
(LoweryM )
UPD Axitinib changed to protein kinase inhibitor
09/05/2018 11:15:28
(LoweryM )
UPD Axitinib approved
11/08/2017 15:23:53
(LoweryM )
UPD Axitinib b
01/02/2017 14:34:21
(DavidS )
UPD Axitinib b
23/01/2017 15:03:45
(WhitehallJ )
UPD Axitinib 1mg, 3mg, 5mg, and 7mg tablets b
23/01/2017 09:47:39
(WhitehallJ )
UPD Axitinib (Inlyta®) build
28/11/2016 15:27:12
(DavidS )

 

 
netFormulary